Middle East Healthcare Company SJSC
SAU:4009
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
68
131.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Middle East Healthcare Company SJSC
Middle East Healthcare Company SJSC
Cost of Revenue
Middle East Healthcare Company SJSC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Middle East Healthcare Company SJSC
SAU:4009
|
Cost of Revenue
-ď·Ľ1.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cost of Revenue
-ď·Ľ1.9B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-15%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cost of Revenue
-ď·Ľ753.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cost of Revenue
-ď·Ľ1.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cost of Revenue
-ď·Ľ6.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cost of Revenue
-ď·Ľ1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Middle East Healthcare Company SJSC
Glance View
Saudi German Health engages in the management and operation of hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, and pharmacies. The firm manages, operates and maintains hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies purchasing of lands to construct buildings and investment for the Company in medical projects.
See Also
What is Middle East Healthcare Company SJSC's Cost of Revenue?
Cost of Revenue
-1.3B
SAR
Based on the financial report for Jun 30, 2024, Middle East Healthcare Company SJSC's Cost of Revenue amounts to -1.3B SAR.
What is Middle East Healthcare Company SJSC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-7%
Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Middle East Healthcare Company SJSC have been -6% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
